NCT00002928View on ClinicalTrials.gov

Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1997

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2001

Conditions
Ovarian Cancer
Interventions
DRUG

paclitaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002928 - Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer | Biotech Hunter | Biotech Hunter